Trial intelligence / Profile preview

Pilot study of glimepiride-associated hypoglycaemia in older moderately frail patients with type 2 diabetes

2015-003032-13Phase 4Terminated

Sponsor
University of Campania Luigi Vanvitelli
Start
Sep 2021
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of glimepiride in type 2 diabetes mellitus (T2DM), sponsored by University of Campania Luigi Vanvitelli. Started Sep 2021; status: terminated.

02

Drugs

glimepiride
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2015-003032-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-003032-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call